Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.

NCT00365131 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.

NCT NCT00365131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00365131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.
Lead sponsor
Genzyme, a Sanofi Company
Phase
Phase 4
Overall status
Completed
Start date
December 31, 1997
Completion date
July 31, 2004
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebroside lipidosis syndrome, clucocerebrosidase deficiency disease, gaucher disease type i, gaucher disease, non-neuronopathic form, glucosylceramide beta-glucosidase deficiency disease